Form 4: DENTSPLY SIRONA Director Acquires Phantom Stock

DENTSPLY SIRONA Inc. director Jonathan Jay Mazelsky acquired phantom stock units valued at $10.56 per share, representing a total of 2,841.8303 units.

Summary

• Jonathan Jay Mazelsky, a Director at DENTSPLY SIRONA Inc., acquired 2,841.8303 units of phantom stock on June 30, 2026.
• These phantom stock units are economically equivalent to shares of common stock and will be payable in common stock upon the reporting person's termination of service as a director.
• The acquisition was made under a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant to a director under a pre-established plan, rather than a significant new development or financial event.

Positives

• Director Mazelsky's acquisition of phantom stock indicates continued commitment and alignment with the company's long-term performance.
• The transaction was made under a Rule 10b5-1(c) plan, suggesting a pre-determined and structured approach to equity transactions.

Risks

• The value of the phantom stock is tied to the future performance of DENTSPLY SIRONA's common stock, which is subject to market volatility and company-specific risks.
• The shares are payable upon termination of service, meaning the reporting person may not have immediate access to the underlying equity.

Future Outlook

The phantom stock units will be payable in common stock following the reporting person's termination of service as a director, indicating a long-term incentive and retention mechanism.

Industry Context

StockSavvy.ai notes that director equity grants, particularly through phantom stock plans, are common in the medical device industry as a tool for aligning executive interests with shareholder value and retaining key leadership.

Stakeholder Impact

• Shareholders: The transaction reinforces director alignment with shareholder interests through equity ownership, though it does not immediately dilute or increase share count.

Next Steps

• Upon termination of service as a director, Jonathan Jay Mazelsky will receive common stock equivalent to the phantom stock units held.

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Director, Phantom Stock, Beneficial Ownership, Equity, Rule 10b5-1(c)